2,8-dibrimodibenzofuran

2,8-Dibromodibenzofuran (CAS 10016-52-1) is a pharmaceutical-grade intermediate distributed by Nanjing King-Pharm Co., Ltd., which does not manufacture the compound itself. Sales are currently limited to the North American market, and the listing provides no further descriptive detail beyond the compound's identity.